In vitro anti-tumour activity of alpha-galactosylceramide-stimulated human invariant Valpha24+NKT cells against melanoma.
about
Cancer chemopreventive and anticancer evaluation of extracts and fractions from marine macro- and microorganisms collected from Twilight Zone waters around Guam.Bioactive substances with anti-neoplastic efficacy from marine invertebrates: Porifera and Coelenterata.Accumulation of invariant NKT cells with increased IFN-γ production in persistent high-risk HPV-infected high-grade cervical intraepithelial neoplasia.Regulation of antitumour immunity by CD1d-restricted NKT cells.Going both ways: immune regulation via CD1d-dependent NKT cells.Modulation of human Valpha24(+)Vbeta11(+) NKT cells by age, malignancy and conventional anticancer therapies.Stimulation of invariant natural killer T cells by α-Galactosylceramide activates the JAK-STAT pathway in endothelial cells and reduces angiogenesis in the 5T33 multiple myeloma model.Frequency and phenotype of circulating Valpha24/Vbeta11 double-positive natural killer T cells during hepatitis C virus infection.Small-molecule Bcl-2 inhibitors sensitise tumour cells to immune-mediated destruction.alpha-Galactosylceramide and novel synthetic glycolipids directly induce the innate host defense pathway and have direct activity against hepatitis B and C viruses.Natural killer T-cell characterization through gene expression profiling: an account of versatility bridging T helper type 1 (Th1), Th2 and Th17 immune responses.Identification of membrane-type matrix metalloproteinase-1 as a target of the beta-catenin/Tcf4 complex in human colorectal cancers.The Role of CD1d and MR1 Restricted T Cells in the Liver
P2860
Q33743718-1BC1F8E0-2629-4752-A91C-6EC0C92F7028Q35540357-43BB7A1E-91ED-4581-A9FE-872492F7EFCDQ35559432-8155F6D4-40DF-4500-9480-46C5B162D72BQ35798173-7877921F-B89B-498D-A003-BD3AF2B39FA4Q35951531-6DA11677-8FF7-4256-97D9-D7B173F186ACQ36695207-2B720484-4B59-47AD-827C-B0785036D4CAQ38964255-2F11B11A-E01A-4705-BEBC-77A09FFC7549Q39699616-5FE7C2F9-37EF-4FA0-923C-EBA9D40747F6Q40169102-BAE3AE9F-6870-4D0A-8CCC-D1A28CED0253Q40553724-D7471F2A-3F34-4179-BB7F-7318BE7E4016Q52922958-137B2C34-5B77-4D03-A872-A910B50974AEQ53387673-9386976A-031F-46A3-B2FF-11B1FCD0D58DQ58697988-2ED0CC84-8E85-48A5-ABFA-EFC380DF0CFD
P2860
In vitro anti-tumour activity of alpha-galactosylceramide-stimulated human invariant Valpha24+NKT cells against melanoma.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
In vitro anti-tumour activity ...... 24+NKT cells against melanoma.
@en
In vitro anti-tumour activity ...... 24+NKT cells against melanoma.
@nl
type
label
In vitro anti-tumour activity ...... 24+NKT cells against melanoma.
@en
In vitro anti-tumour activity ...... 24+NKT cells against melanoma.
@nl
prefLabel
In vitro anti-tumour activity ...... 24+NKT cells against melanoma.
@en
In vitro anti-tumour activity ...... 24+NKT cells against melanoma.
@nl
P2093
P2860
P356
P1476
In vitro anti-tumour activity ...... a24+NKT cells against melanoma
@en
P2093
Ishihara S
Ishikawa Y
Tadokoro K
P2860
P2888
P304
P356
10.1054/BJOC.2001.1973
P407
P50
P577
2001-09-01T00:00:00Z
P5875
P6179
1006193004